carA Family assigned · medium auto-curated

H37Rv Rv1383 · MTBC0 mtbc0_001484 · 376 aa · 1565315–1566445 MTBC0 (+) · RefSeq NP_215899.1

Genomic neighbourhood (genome browser)

Open in full genome browser →

This gene (outlined) in its genomic context; arrows are neighbouring genes coloured by verdict. Click any gene to navigate. Pan and zoom in the full browser.

Annotation: from legacy to revised

Legacy (H37Rv / Mycobrowser)carbamoyl-phosphate synthase small subunit
MTBC0 PGAP re-annotationglutamine-hydrolyzing carbamoyl-phosphate synthase small subunit
Revised (this work)Glutamine-hydrolyzing carbamoyl-phosphate synthase small subunit. Pfam: CPSase_sm_chain (PF00988.29), GATase (PF00117.35), Peptidase_C26 (PF07722.20).
Functional category (TubercuList)intermediary metabolism and respiration

Auto-curated: this verdict and function were generated by rules from PGAP + Pfam + Foldseek and have not been hand-reviewed.

In the literature (TB corpus sweep) 8 publications

8 TB publications mention this gene. 8 publications discuss this gene (count verified against title and abstract text). Queried separately, 8 records carry a M. tuberculosis context and none a non-TB mycobacterial context. The three counts come from three distinct PubMed queries (the total is text-verified, the context counts are raw query volumes), so they neither partition the total nor need to add up to it.

5 of 8: the most recently indexed records of the curated sweep at its date, not necessarily the most recent papers on this gene — the exhaustive list below is later and broader and may hold newer ones.
PublicationDate
Carbapenem Antibiotics: Recent Update on Synthesis and Pharmacological Activities. doi:10.2174/2589977514666220907141939 2023
Exhaled Mycobacterium tuberculosis output and detection of subclinical disease by face-mask sampling: prospective observational studies. doi:10.1016/S1473-3099(19)30707-8 2020
Screening for infectious diseases in newly arrived asymptomatic immigrants in southern Italy. doi:10.26719/emhj.18.035 2019
Visualization of the Charcoal Agar Resazurin Assay for Semi-quantitative, Medium-throughput Enumeration of Mycobacteria. doi:10.3791/54690 2016
Migrant health: the Apulian model. 2015
49 records returned by the alias sweep

Searched as: Rv1383, carA, Mb1418, ML0535, MMAR_2198, MSMEG_3046, MAB_2828c — each in conjunction with a mycobacterial context term. Swept 2026-09-07.

This count disagrees with the 8 reported above. The two come from different methods and both are shown rather than one being silently overwritten. The figure above comes from the older curated source, which missed this gene; the sweep below queries every alias of the gene in a mycobacterial context. Where they differ this way, the list below is the one you can check line by line.

PublicationJournalYear
A review of the indications, safety, and efficacy of deucravacitinib: An expert consensus panel. doi:10.25251/ymnfwz12 Dermatol Online J 2026
Guselkumab Safety in Patients With Latent Tuberculosis: Analysis of 11 Studies in Psoriatic Disease. doi:10.1111/1346-8138.70314 J Dermatol 2026
Response to "Elevated risk of active tuberculosis with interleukin (IL)-17, IL-23, IL-12/23, Janus kinase inhibitors, cyclosporine, and tumor necrosis factor-α inhibitors compared with the general population: A population-based analysis using TriNetX". doi:10.1016/j.jaad.2026.03.114 J Am Acad Dermatol 2026
Bimekizumab longer-term safety profile in adult patients with axial spondyloarthritis or psoriatic arthritis: an updated analysis of six phase IIb/III clinical studies. doi:10.1136/rmdopen-2025-006174 RMD Open 2026
The need for interconnected global biorepositories from tuberculosis studies to address fundamental questions at scale. doi:10.1016/j.lanmic.2025.101279 Lancet Microbe 2026
Global biological sample collections from tuberculosis studies: a scoping review. doi:10.1016/j.lanmic.2025.101287 Lancet Microbe 2026
Joint position statement from the National Psoriasis Foundation Medical Board and the International Psoriasis Council on routine testing for latent tuberculosis infection prior to and during treatment of psoriasis patients with interleukin 17 or interleukin 23 inhibitors. doi:10.1016/j.jaad.2025.11.033 J Am Acad Dermatol 2026
Comorbidities in prurigo nodularis. doi:10.1016/j.clindermatol.2025.09.001 Clin Dermatol 2025
Assessment of structural and functional characteristics of HDL and LDL in lung cancer patients in order to elucidate mechanisms of cholesterol metabolic pathways disorders. doi:10.1016/j.clinbiochem.2025.111012 Clin Biochem 2025
Reconsidering interferon gamma release assay thresholds and annual retesting in patients receiving biologic therapy for psoriasis. doi:10.1016/j.jaad.2025.06.011 J Am Acad Dermatol 2025
Relationship between culture conversion and clinical outcomes in nontuberculous mycobacterial pulmonary disease: Narrative review. doi:10.1016/j.rmed.2025.108052 Respir Med 2025
Long-Term Safety of Risankizumab in Patients with Psoriatic Disease: A Comprehensive Analysis from Clinical Trials. doi:10.1007/s13555-024-01238-5 Dermatol Ther (Heidelb) 2024
Long-Term Safety of Guselkumab in Patients with Psoriatic Disease: An Integrated Analysis of Eleven Phase II/III Clinical Studies in Psoriasis and Psoriatic Arthritis. doi:10.1007/s40264-023-01361-w Drug Saf 2024
Deucravacitinib: a novel TYK2 inhibitor for the treatment of moderate-to-severe psoriasis. doi:10.1177/24755303231201336 J Psoriasis Psoriatic Arthritis 2023
Safety of IL-23 p19 Inhibitors for the Treatment of Patients With Moderate-to-Severe Plaque Psoriasis: A Narrative Review. doi:10.1007/s12325-023-02568-0 Adv Ther 2023
Safety of guselkumab treatment for up to 5 years in patients with moderate-to-severe psoriasis: pooled analyses across seven clinical trials with more than 8600 patient-years of exposure. doi:10.1093/bjd/ljad115 Br J Dermatol 2023
Carbapenem Antibiotics: Recent Update on Synthesis and Pharmacological Activities. doi:10.2174/2589977514666220907141939 Curr Drug Res Rev 2023
Cathepsin K in Pathological Conditions and New Therapeutic and Diagnostic Perspectives. doi:10.3390/ijms232213762 Int J Mol Sci 2022
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. doi:10.1002/14651858.CD014217 Cochrane Database Syst Rev 2022
Long-term Safety of Secukinumab Over Five Years in Patients with Moderate-to-severe Plaque Psoriasis, Psoriatic Arthritis and Ankylosing Spondylitis: Update on Integrated Pooled Clinical Trial and Post-marketing Surveillance Data. doi:10.2340/actadv.v102.563 Acta Derm Venereol 2022
Diagnostic complexity of rifampicin-induced coagulopathy in a patient with spontaneous muscle bleeding: A case report. doi:10.1097/MD.0000000000026234 Medicine (Baltimore) 2021
Phosphorylation on PstP Regulates Cell Wall Metabolism and Antibiotic Tolerance in Mycobacterium smegmatis. doi:10.1128/JB.00563-20 J Bacteriol 2021
Treatment of Psoriasis with Secukinumab in Challenging Patient Scenarios: A Review of the Available Evidence. doi:10.1007/s13555-020-00373-z Dermatol Ther (Heidelb) 2020
Exhaled Mycobacterium tuberculosis output and detection of subclinical disease by face-mask sampling: prospective observational studies. doi:10.1016/S1473-3099(19)30707-8 Lancet Infect Dis 2020
The mycobacterial cell envelope - a moving target. doi:10.1038/s41579-019-0273-7 Nat Rev Microbiol 2020
Screening for infectious diseases in newly arrived asymptomatic immigrants in southern Italy. doi:10.26719/emhj.18.035 East Mediterr Health J 2019
Mycobacterium abscessus Cells Have Altered Antibiotic Tolerance and Surface Glycolipids in Artificial Cystic Fibrosis Sputum Medium. doi:10.1128/AAC.02488-18 Antimicrob Agents Chemother 2019
Characterization of Conserved and Novel Septal Factors in Mycobacterium smegmatis. doi:10.1128/JB.00649-17 J Bacteriol 2018
Evaluation of a chest radiograph reading and recording system for tuberculosis in a HIV-positive cohort. doi:10.1016/j.crad.2017.01.008 Clin Radiol 2017
Hsp65-Producing Lactococcus lactis Prevents Inflammatory Intestinal Disease in Mice by IL-10- and TLR2-Dependent Pathways. doi:10.3389/fimmu.2017.00030 Front Immunol 2017
Visualization of the Charcoal Agar Resazurin Assay for Semi-quantitative, Medium-throughput Enumeration of Mycobacteria. doi:10.3791/54690 J Vis Exp 2016
Migrant health: the Apulian model. Epidemiol Prev 2015
Rapid, Semiquantitative Assay To Discriminate among Compounds with Activity against Replicating or Nonreplicating Mycobacterium tuberculosis. doi:10.1128/AAC.00803-15 Antimicrob Agents Chemother 2015
Metagenomic analysis reveals potential biodegradation pathways of persistent pesticides in freshwater and marine sediments. doi:10.1016/j.scitotenv.2013.10.076 Sci Total Environ 2014
The CARA tuberculosis project in Karbala. doi:10.1080/13623699.2013.765187 names it Med Confl Surviv 2013
Experience of Médecins Sans Frontières in laboratory medicine in resource-limited settings. doi:10.1515/cclm-2011-0618 Clin Chem Lab Med 2012
TSH-CHECK-1 test: diagnostic accuracy and potential application to initiating treatment for hypothyroidism in patients on anti-tuberculosis drugs. doi:10.1371/journal.pone.0033704 PLoS One 2012
[Lupus miliaris disseminatus faciei]. doi:10.1016/s0001-7310(05)73064-7 Actas Dermosifiliogr 2005
Spontaneous small bowel perforations due to intestinal tuberculosis should not be repaired by simple closure. doi:10.1016/j.gassur.2004.09.034 J Gastrointest Surg 2005
Identification of greA encoding a transcriptional elongation factor as a member of the carA-orf-carB-greA operon in Pseudomonas aeruginosa PAO1. doi:10.1128/jb.179.9.3043-3046.1997 names it J Bacteriol 1997
[Progressive multifocal leukoencephalopathy and AIDS. Response to cytarabine]. An Med Interna 1994
[OUR EXPERIENCE WITH THE TREATMENT OF KOCH'S BACILLUS POSITIVE CHRONIC INFECTION BEFORE THE APPEARANCE OF INDIRECT RESISTANCE]. Tuberkuloza 1964
[CLINICAL AND THERAPEUTIC CONSIDERATIONS ON PULMONARY TUBERCULOSIS AMONG ALCOHOLICS. I]. Tuberkuloza 1963
[Chronic tubercular thyroiditis. Description of a clinical case]. Riv Patol Clin 1961
[Review treatment of pulmonary tuberculosis. II]. Rev Clin Esp 1956
[Difficult pregnancy]. Bull Mem Soc Med Hop Paris 1956
[Disseminated miliary tuberculosis of the face: disseminated follicular lupus of Tilbury Fos; miliary lupoid; miliary lupus of the face]. Actas Dermosifiliogr 1955
[Functional readaptation of tuberculotics]. Rev Tuberc 1955
[Lupus planus tuberculosus of the face treated with isonicotinic acid hydrazide]. Actas Dermosifiliogr 1953

Title+abstract index only: a paper that names this gene solely in its body text, a figure legend or a supplement is invisible here. That is why this list sits beside the curated layer rather than replacing it - Rv0007's characterisation, found by a full-text sweep, returns zero in this one. Absence from this list is not absence from the literature. Source: PubMed E-utilities sweep (esearch + esummary), every alias of the gene searched in conjunction with a mycobacterial context term; ambiguous common-word aliases excluded. phase198, 2026-09-06.

This layer CITES the literature and adds context; it does not change the verdict or the function stated elsewhere in this fiche. This distinguishes a gene that is dark because nobody has looked from one that is dark despite having been studied. Source: PubMed (whole): H37Rv locus tag + GENE NAME + ortholog identifiers (Mb…, MMAR_…, MSMEG_…, ML…, MAB_…), under a mycobacterial context filter; hits verified against the abstract text. Species-context counts distinguish M. tuberculosis literature from literature on other mycobacteria. phase76/phase77, 2026-07-13.

Genomic-neighbour overlap (structural caveat) co-directional · 0 % of gene

NeighbourRv1382 (Rv1382, + strand)
Overlap4 bp, 0 % of this gene's length

co-directional overlap: ordinary (e.g. shared stop/start codons in an operon), not the Rv2438A-type artefact P20.1, derived from GFF3 gene coordinates, 2026-08-03.

CRISPRi vulnerability

Vulnerability index -6.03 (95% CI -7.13 to -4.84). A more negative index = more vulnerable to knockdown (better drug-target quality); indicative threshold VI ≤ -6 = highly vulnerable.

Quantitative CRISPRi knockdown, graded (finer than binary Tn-seq essentiality). Source: CRISPRi vulnerability index (Bosch 2021, supplementary Table S2 'mmc3.xlsx', bulk import via Europe PMC -- supersedes the per-gene pebble.rockefeller.edu scrape of phase46_crispri_vulnerability.py).

Legacy record & comparison (Mycobrowser)

Mycobrowser functionInvolved in both arginine and pyrimidine biosynthesis [catalytic activity: 2 ATP + L-glutamine + CO(2) + H(2)O = 2 ADP + phosphate + glutamate + carbamoyl phosphate]
Mycobrowser EC 6.3.5.5 · agrees with the atlas

The legacy Mycobrowser record is shown for verification. Mycobrowser is no longer maintained; its EC numbers predate recent nomenclature revisions, so a class change usually reflects re-numbering, not a conflict.

Orthologues (reciprocal best hits across mycobacteria)

M. bovis Mb1418 · 99.5% identity
M. leprae ML0535 · 85.4% identity
M. marinum MMAR_2198 · 85.7% identity
M. smegmatis MSMEG_3046 · 82.8% identity
M. orygis RJtmp_001463 · 99.7% identity
M. abscessus MAB_2828c · 77.6% identity

Reciprocal-best-hit orthologues (DIAMOND) against the Mycobrowser reference proteomes. A missing species is informative: e.g. a gene absent from M. leprae was likely lost in its reductive genome evolution. Locus tags link to Mycobrowser.

Curated reference (UniProt)

UniProt P9WPK5 SwissProt · reviewed · Evidence at protein level
UniProt nameCarbamoyl phosphate synthase small chain
EC (curated) EC 6.3.5.5
Curated functionSmall subunit of the glutamine-dependent carbamoyl phosphate synthetase (CPSase). CPSase catalyzes the formation of carbamoyl phosphate from the ammonia moiety of glutamine, carbonate, and phosphate donated by ATP, constituting the first step of 2 biosynthetic pathways, one leading to arginine and/or urea and the other to pyrimidine nucleotides. The small subunit (glutamine amidotransferase) binds and cleaves glutamine to supply the large subunit with the substrate ammonia.

Functional vocabulary (eggNOG-mapper, orthology transfer)

COG category F Nucleotide transport and metabolism
Preferred namecarA
eggNOG descriptionBelongs to the CarA family
Orthologous groupCOG0505
EC number EC 6.3.5.5
KEGG orthology K01956
KEGG pathways map00240, map00250, map01100
KEGG modules M00051
Gene Ontology (45) GO:0000050, GO:0005575, GO:0005622, GO:0005623, GO:0005737, GO:0005951, GO:0006082, GO:0006520, GO:0006525, GO:0006526, GO:0006807, GO:0008150 +33 more

Orthology-based transfer (eggNOG 5.0.2, diamond). EC/KO/GO/CAZy are computed annotations, not manual curation; cross-check against the primary literature before treating a specific reaction as established.

Conservation & selection (intra-MTBC, 142 601 strains, snapshot of 2026-09-29)

pN/pS 2.091 · quasi-invariant (7 sites), pN/pS underpowered
Polymorphic sites (≥ 0.1% of strains) 1 synonymous, 6 missense, 0 nonsense, 0 frameshift

pN/pS from segregating SNPs (singletons removed) normalised by possible sites. Low pN/pS = purifying selection (a strong signal that a "hypothetical" is a real, constrained gene). A high pN/pS is ambiguous: relaxed constraint or positive selection (drug resistance, antigenic variation) inflate it; e.g. rpoB/katG/pncA score high here for resistance, not loss of function. A clonal disruption (one allele over a clade) suggests lineage pseudogenisation; a convergent one (many independent alleles) is typical of resistance loss-of-function.

Outgroup conservation (beyond the MTBC) Bacteria

M. canettii dN/dS (deep-divergence selection) 0.081 · 16 consensus substitution(s)
under purifying selection vs M. canettii (deep divergence; dN/dS=0.081) — a real, constrained gene predating the MTBC clonal expansion
Limitation: dN/dS mixes fixed canettii-H37Rv divergence with intra-canettii polymorphism, and is not polarised (the per-gene repolarisation is not viable: 79 % of the consensus SPDI lie outside the polarised table).
Genus-wide presence (~53 non-MTBC Mycobacterium) present in 53/53 (100%) · mean identity 87.0% · 4/4 closest MTBAP relatives
conserved across the genus (present in 53/53 non-MTBC Mycobacterium genomes, incl. distant relatives) — an ancient core gene predating the genus radiation
Phylostratum (deepest detected homolog) MTBC-specific → Mycobacterium → Mycobacteriaceae → Corynebacteriales → Actinomycetia → Bacteria
detected in 13/13 non-Mycobacterium reference genomes (down to Bacteria) · mean identity 62.6%
detected down to outside the phylum (Proteobacteria/Firmicutes controls) — a universally conserved, ancient bacterial gene

Two orthogonal outgroup signals. M. canettii (the immediate outgroup) gives a deep-divergence dN/dS (a low value confirms a constrained, real gene; shown as confident only at ≥8 substitutions, else flagged low-power). Genus-wide presence/absence (tblastn vs assembled non-MTBC genomes) places the gene on the ancient-core ↔ MTBC-specific axis: a gene absent even from the closest MTBAP relatives is a candidate MTBC-specific innovation (possible host-adaptation factor, to confirm by synteny). The phylostratum extends that axis outside the genus (tblastn vs 13 reference genomes spanning Mycobacteriaceae → Corynebacteriales → Actinomycetia → outside the phylum): it is the deepest clade in which a homolog is still detected, i.e. a proxy for gene age. Read it with the null model in mind: a shallow (young) stratum can also reflect homology-detection failure for short or fast-evolving ORFs, so it is a descriptive axis, not a proof of novelty.

Essentiality (transposon mutagenesis) essential

DeJesus 2017 callES · essential
What the call meansessential: insertions absent across the whole ORF
TA sites (Himar1) 13 in the ORF — 13 in the essential state, 0 growth-defect, 0 non-essential, 0 growth-advantage. Saturation 0.077, mean read count 1. A region of the protein devoid of TA sites is invisible to this assay: nothing can be inferred about it, in either direction.
All 13 sites lie in this ORF alone (no overlapping CDS shares any), so the call is attributable to this gene.

Genome-wide Himar1 transposon essentiality in H37Rv (DeJesus 2017). An essential call (ES/ESD/GD) is strong, independent evidence that a "hypothetical" locus encodes a functional, selectively required gene — orthogonal to intra-species conservation.

Proteomics (mass spectrometry) detected

MS detectiondetected in 12 of 16 independent MS datasets
Integrated abundance98.2 ppm · rank 1306/3519 (62.9th percentile)

Detection by mass spectrometry is direct, experimental evidence that the protein product exists — orthogonal to sequence conservation and to Tn-seq essentiality, and especially decisive for a "hypothetical" locus. Read the dataset count as abundance, not as replication. Measured across this atlas (3,491 detected proteins), the number of datasets a protein appears in tracks its abundance almost monotonically: median 1.2 ppm at 1 dataset of 16, 27 ppm at 10, 392 ppm at 15, 1,325 ppm at 16 — three orders of magnitude. A high count therefore says the protein is abundant more than it says several independent experiments confirmed it. What the count does establish, at any value, is that the product exists.

Predicted localisation (DeepTMHMM + lipobox) no export signal, no TM helix

Predictionno signal peptide, no TM helix (DeepTMHMM class GLOB)
DeepTMHMM classGLOB

A verified absence of signals, which is not a compartment. No Sec/Tat signal peptide, no transmembrane helix and no lipobox were found on this sequence. The predictor reports topology and export signals; it does not measure where the protein ends up, so this page draws no cytoplasmic conclusion from it. In M. tuberculosis that reservation is not theoretical: the 12 Esx paralogues of this atlas — EsxA/ESAT-6 and EsxB/CFP-10 among them, the best-established secreted proteins of the species — carry this very call, because substrates of the type VII (ESX) secretion system leave no recognisable signal. « Secreted » and « no signal peptide » are true together here.

Transmembrane topology and signal peptide from DeepTMHMM (deep-learning reference predictor); lipoproteins from a (myco)bacterial lipobox motif. A sequence-based prediction of subcellular context.

Physico-chemical properties (computed, ProtParam)

Length376 aa
Molecular weight39.8 kDa
Theoretical pI5.89
GRAVY-0.071 (hydrophilic)
Aliphatic index83.3
Aromaticity0.072
Instability index28.2 (stable)

Computed from the ancestral MTBC0 sequence with the ExPASy ProtParam method (Biopython). Descriptive biophysical context: a positive GRAVY flags a hydrophobic (often membrane) protein, a high instability index (>40) predicts a short in-vitro half-life, an extreme pI hints at compartment or binding partner.

Domains (Pfam, hmmscan --cut_ga)

PfamAccessioni-EvalueResiduesDescription
CPSase_sm_chainPF00988.29 5.2e-476–132 Carbamoyl-phosphate synthase small chain, CPSase domain
GATasePF00117.35 5.8e-42188–369 Glutamine amidotransferase class-I
Peptidase_C26PF07722.20 3.2e-07240–352 Peptidase C26

3D structure (interactive — Mol*/pdbe-molstar)

No experimental structure is deposited for this gene: showing the AlphaFold DB predicted model (mean pLDDT 96.9, very high), coloured by per-residue confidence (dark blue = very high, orange/red = low — treat low-confidence regions as unreliable, especially termini and loops). Drag to rotate, scroll to zoom.

Structural search (AlphaFold DB model, Foldseek vs PDB — genome-wide) pLDDT 96.9

PDB hitprobTM (aln)TM (query)TM (target)Seq. id.Cov. q / tE-valueDescription
1a9x-assembly1_B 1.00 0.94 0.94 0.93 43% 100% / 99% 5.6e-52 sig 1a9x-assembly1_B CARBAMOYL PHOSPHATE SYNTHETASE: CAUGHT IN THE ACT OF GLUTAMINE HYDROLYSIS
1cs0-assembly1_F 1.00 0.93 0.93 0.92 43% 100% / 99% 4.4e-52 sig 1cs0-assembly1_F Crystal structure of carbamoyl phosphate synthetase complexed at CYS269 in the small subunit with the tetrahedral mimic l-glutamate gamma-semialdehyde
1jdb-assembly1_F 1.00 0.93 0.93 0.92 43% 100% / 99% 7.5e-52 sig 1jdb-assembly1_F CARBAMOYL PHOSPHATE SYNTHETASE FROM ESCHERICHIA COLI
1t36-assembly1_D 1.00 0.92 0.92 0.92 44% 99% / 99% 6.3e-52 sig 1t36-assembly1_D Crystal structure of E. coli carbamoyl phosphate synthetase small subunit mutant C248D complexed with uridine 5'-monophosphate
1c30-assembly1_B 1.00 0.93 0.93 0.92 43% 99% / 99% 4.6e-51 sig 1c30-assembly1_B CRYSTAL STRUCTURE OF CARBAMOYL PHOSPHATE SYNTHETASE: SMALL SUBUNIT MUTATION C269S

Foldseek search of the AlphaFold DB model (mean pLDDT 96.9, gated at 70) against the PDB — a genome-wide extension of the ESMFold dark-gene search that also covers proteins beyond the single-sequence length limit. Confident structural neighbours (E < 0.01) shown.

Genomic context (neighbours & predicted operon) operon of 7

Upstream (5' on genome)Rv1382 (+ strand, -4 bp gap)
Downstream (3' on genome)carB (+ strand, -1 bp gap)
Predicted operon pyrR · pyrB · pyrC · Rv1382 · carA · carB · pyrF

Neighbours from the H37Rv annotation (+ strand). The operon is predicted by co-directional intergenic distance (same strand, gaps ≤50 bp) — a transcription-unit hypothesis, not a mapped TSS. For a "hypothetical", co-transcription with a characterised operon is a concrete functional lead (complements the STRING neighborhood channel below).

Published operon evidence (two independent sources)

Roback 2007 (logistic regression: distance + expression correlation, 474 microarrays) operon of 4: pyrB · pyrC · Rv1382 · carA — disagrees with the distance heuristic above
REMap 2016 (RNA-seq coverage continuity, CDC1551, tag MT1427) exponential phase: operon of 6, Rv1379 · Rv1380 · Rv1381 · Rv1382 · Rv1383 · Rv1384 (coverage 13.51)
not expressed (stationary phase) — disagrees with the distance heuristic above

Two independent published operon maps, cited alongside the distance heuristic above: an association corroborating or contradicting the heuristic, never proof of shared function. REMap's RNA-seq coverage continuity is the most direct of the three signals; Roback's logistic regression and the intergenic-distance heuristic are statistical proxies.

Transcriptional regulation (signed TRN: ChIP-seq + TFOE)

Regulated by (1 TF) kstR (activates)

Regulatory edges from the ISB signed transcriptional regulatory network (TF ChIP-seq binding, Minch 2015 + TF-overexpression response, Rustad 2014). An edge is regulatory evidence (binding and/or expression change), not necessarily direct. For a "hypothetical", membership in a known regulon (e.g. DosR dormancy, PhoP virulence) is a physiological-context lead, not a function.

Condition: Condition-blind by construction. These edges come from transcription-factor OVEREXPRESSION in a single laboratory condition, so a listed regulator is not a claim that it governs this gene in every circumstance. Measured counter-examples exist within this atlas (see Rv2516c, where the DosR regulon collapses under moxifloxacin while the gene itself rises). Read a regulator as 'capable of shifting this gene', and look for the condition before building a hypothesis on it.

Functional interaction network (STRING v12, guilt-by-association)

Explore full network →

Node colour = verdict, dashed = still uncharacterised; edge colour = evidence (green experimental, orange genomic-context, grey co-expression), width ∝ score. Click a partner to open its page; "Explore full network" to walk the graph.

Closest characterised functional partner: pyrB (aspartate carbamoyltransferase), high confidence (score 1000, all STRING channels except text-mining; the partner is chosen on its genomic-context evidence). The pair is recorded in a curated database (pathway or complex membership) for M. tuberculosis genes themselves (score ≥ 200): a curated association, not a measurement in this organism.

Showing the 15 strongest of this gene's 70 partners at medium confidence (32 at high confidence). The table is an extract, not a neighbourhood: across the proteome the real median degree is 34 while the served median is 15, so no hub, degree distribution or centrality may be read on this table. None of the 70 partners rests on an interaction measured in M. tuberculosis itself.

PartnerProductScoreNo text-miningChannels (≥400)
Rv1380 pyrB curated aspartate carbamoyltransferase 999 1000 ctx neighborhood:882 fusion:900 cooccurence:422 coexpression:865 database:900 textmining:449
Rv1381 pyrC dihydroorotase 999 1000 ctx neighborhood:882 fusion:900 coexpression:958 textmining:905
Rv1384 carB exp (transferred) curated carbamoyl-phosphate synthase large subunit 999 1000 ctx neighborhood:882 fusion:900 cooccurence:774 coexpression:967 experimental:928 database:900 textmining:453
Rv1385 pyrF orotidine 5'-phosphate decarboxylase 989 988 ctx neighborhood:881 coexpression:864
Rv1382 hypothetical protein 977 976 ctx neighborhood:882 coexpression:805
Rv1379 pyrR bifunctional pyrimidine operon regulatory protein/uracil phosphoribosyltransferase 972 968 ctx neighborhood:882 coexpression:736
Rv0808 purF curated amidophosphoribosyltransferase 969 967 coexpression:594 database:900
Rv3859c gltB curated glutamate synthase large subunit 954 953 ctx neighborhood:544 database:900
Rv1656 argF curated ornithine carbamoyltransferase 957 951 ctx fusion:550 coexpression:453 database:800
Rv0788 purQ curated phosphoribosylformylglycinamidine synthase 949 947 coexpression:463 database:900
Rv2222c glnA2 curated glutamine synthetase 923 919 database:900
Rv2220 glnA1 curated glutamine synthetase 914 909 database:900
Rv1878 glnA3 curated glutamine synthetase GlnA 914 909 database:900
Rv2139 pyrD dihydroorotate dehydrogenase 929 908 coexpression:849
Rv3436c glmS curated glucosamine--fructose-6-phosphate aminotransferase 913 908 database:900

STRING combines evidence channels (neighborhood, fusion, cooccurrence, coexpression, experimental, database, text-mining) into a 0–1000 score. The ctx badge marks edges carried by the genomic-context channels (conserved neighborhood, fusion, phylogenetic co-occurrence), which are independent of orthology and structure and the strongest signal for an unknown gene. The no text-mining column recomputes the score from data alone, so a link that does not depend on the literature is visible. Association is a function hypothesis, not proof: corroborate with the operon context and the primary literature before assigning a function.

Where the experimental evidence comes from, and why it matters here. STRING's experimental channel fuses interactions measured in M. tuberculosis with interactions measured in another organism and transferred to this pair by orthology. The two are not equivalent for this atlas, whose standing rule is that better studied elsewhere is not a function established in M. tuberculosis. Measured on the served network: of the 38 229 partner pairs shown across the atlas, 13 483 partner rows carry a non-zero experimental channel, and only 106 pairs rest on an interaction measured in M. tuberculosis itself — 0.3 % of the network. Those 106 are long-established complexes (ESX-1/ESAT-6, RNA polymerase with CarD and RbpA, the Pup–Mpa proteasome, gyrase, Emb, GarA with PknB and PknG, the Rel modules); no still-uncharacterised gene is among them. The reason is not a gap in this atlas but in the literature: there is almost no experimental interactome of this bacterium, IntAct holding 134 curated protein pairs for a ~4 000-gene proteome. A exp (transferred) badge is therefore a lead, never a measurement, and an absence of badge is not evidence that the pair does not interact.

Evidence

  • Legacy H37Rv annotation: carbamoyl-phosphate synthase small subunit
  • MTBC0 PGAP product: glutamine-hydrolyzing carbamoyl-phosphate synthase small subunit
  • Pfam (hmmscan --cut_ga): CPSase_sm_chain PF00988.29 (E=5e-47), GATase PF00117.35 (E=6e-42), Peptidase_C26 PF07722.20 (E=3e-07)
  • (auto-curated by rules from PGAP + Pfam + Foldseek; not hand-reviewed)

Sources

  • Ancestral sequence & coordinates: Harrison LB et al. (2024), An imputed ancestral reference genome for the MTBC, doi:10.1101/2023.09.07.556366
  • Product annotation: NCBI PGAP on MTBC0; legacy from H37Rv NC_000962.3 (RefSeq NP_215899.1)
  • Domains: Pfam-A via hmmscan --cut_ga — CPSase_sm_chain (PF00988.29), GATase (PF00117.35), Peptidase_C26 (PF07722.20)
  • Sequence-level signal: ESM Atlas (EvolutionaryScale × BioHub) — exploratory
  • Controlled vocabulary: eggNOG-mapper 2.1.12 (Cantalapiedra et al. 2021, doi:10.1093/molbev/msab293), eggNOG 5.0 DB (Huerta-Cepas et al. 2019) — OG COG0505
  • Curated reference: UniProt P9WPK5 (SwissProt, reviewed; Evidence at protein level)
  • Intra-MTBC selection: pN/pS and disruption from SPDI variants of 142 601 MTBC strains (this work, local collection vs H37Rv NC_000962.3)
  • Genome-wide structure: AlphaFold DB model (Jumper et al. 2021, doi:10.1038/s41586-021-03819-2; Varadi et al. 2024, doi:10.1093/nar/gkad1011) searched vs PDB with Foldseek (mean pLDDT 96.9)
  • Interaction network: STRING v12.0 (Szklarczyk et al. 2023, doi:10.1093/nar/gkac1000), taxon 83332, CC-BY 4.0 — 70 functional partner(s); context anchor pyrB
  • Essentiality: genome-wide transposon mutagenesis in H37Rv — DeJesus et al. 2017 (mBio, doi:10.1128/mBio.02133-16, CC BY)
  • Proteomics: integrated mass-spectrometry abundance from PaxDb 5.0 (Huang et al. 2023, doi:10.1016/j.mcpro.2023.100640), taxon 83332 — weighted average of 16 datasets, incl. Schubert et al. 2013 (doi:10.1016/j.chom.2013.04.008) and Albrethsen et al. 2013 (doi:10.1074/mcp.M112.018846)
  • Functional category: TubercuList scheme (Cole et al. 1998, doi:10.1038/31159), via Mycobrowser (Kapopoulou et al. 2011, doi:10.1016/j.tube.2010.09.006)
  • Orthologues: reciprocal best hits (DIAMOND, Buchfink et al. 2021, doi:10.1038/s41592-021-01101-x) against Mycobrowser release 5 reference proteomes
  • Genomic context / operon: H37Rv annotation; operon predicted by co-directional intergenic distance (Salgado et al. 2000, doi:10.1073/pnas.030539397)
  • Transcriptional regulation: ISB signed TRN — TF ChIP-seq (Minch et al. 2015, doi:10.1038/ncomms6829) + TF overexpression (Rustad et al. 2014, doi:10.1186/gb-2014-15-11-502)
  • Physico-chemical properties: ExPASy ProtParam method via Biopython (Gasteiger et al. 2005), computed from the MTBC0 sequence
  • Predicted localisation: DeepTMHMM (Hallgren et al. 2022, doi:10.1101/2022.04.08.487609) for transmembrane topology and signal peptide
  • Primary literature: none located yet; annotation rests on the domain/homology sources above.

Ancestral MTBC0 protein sequence

>mtbc0_001484|Rv1383|carA
MSKAVLVLEDGRVFTGRPFGATGQALGEAVFSTGMSGYQETLTDPSYHRQIVVATAPQIGNTGWNGEDSESRGERIWVAGYAVRDPSPRASNWRATGTLEDELIRQRIVGIAGIDTRAVVRHLRSRGSMKAGVFSDGALAEPADLIARVRAQQSMLGADLAGEVSTAEPYVVEPDGPPGVSRFTVAALDLGIKTNTPRNFARRGIRCHVLPASTTFEQIAELNPHGVFLSNGPGDPATADHVVALTREVLGAGIPLFGICFGNQILGRALGLSTYKMVFGHRGINIPVVDHATGRVAVTAQNHGFALQGEAGQSFATPFGPAVVSHTCANDGVVEGVKLVDGRAFSVQYHPEAAAGPHDAEYLFDQFVELMAGEGR